Gutiérrez Orlando M, Judd Suzanne E, Irvin Marguerite R, Zhi Degui, Limdi Nita, Palmer Nicholette D, Rich Stephen S, Sale Michèle M, Freedman Barry I
Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.
Nephrol Dial Transplant. 2016 Apr;31(4):602-8. doi: 10.1093/ndt/gfv229. Epub 2015 Jul 6.
Two independent coding variants in the apolipoprotein L1 gene (APOL1), G1 and G2, strongly associate with nephropathy in African Americans; associations with cardiovascular disease are more controversial. Although APOL1 binds plasma high-density lipoproteins (HDLs), data on APOL1 risk variant associations with HDL subfractions are sparse.
Two APOL1 G1 single nucleotide polymorphisms and the G2 insertion/deletion polymorphism were genotyped in 2010 Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study participants with nuclear magnetic resonance spectroscopy-based lipoprotein subfraction measurements. Linear regression was used to model associations between numbers of APOL1 G1/G2 risk variants and HDL subfractions, adjusting for demographic, clinical and ancestral covariates.
Female sex and higher percentage of African ancestry were positively associated with the number of APOL1 G1/G2 risk alleles. In the unadjusted analysis, mean (standard error) small HDL concentrations (μmol/L) for participants with zero, one and two G1/G2 risk alleles were 19.0 (0.2), 19.7 (0.2) and 19.9 (0.4), respectively (P = 0.02). Adjustment for age, sex, diabetes and African ancestry did not change the results but strengthened the statistical significance (P = 0.004). No significant differences in large or medium HDL, very low-density lipoprotein or low-density lipoprotein particle concentrations were observed by APOL1 genotype.
Greater numbers of APOL1 G1/G2 risk alleles were associated with higher small HDL particle concentrations in African Americans. These results may suggest novel areas of investigation to uncover reasons for the association between APOL1 risk variants with adverse outcomes in African Americans.
载脂蛋白L1基因(APOL1)中的两个独立编码变体G1和G2与非裔美国人的肾病密切相关;与心血管疾病的关联则更具争议性。尽管APOL1与血浆高密度脂蛋白(HDL)结合,但关于APOL1风险变体与HDL亚组分关联的数据却很稀少。
在2010年地理和种族差异导致卒中原因(REGARDS)研究的参与者中,对两个APOL1 G1单核苷酸多态性和G2插入/缺失多态性进行基因分型,并采用基于核磁共振波谱的脂蛋白亚组分测量方法。使用线性回归对APOL1 G1/G2风险变体数量与HDL亚组分之间的关联进行建模,并对人口统计学、临床和祖先协变量进行调整。
女性以及更高比例的非洲血统与APOL1 G1/G2风险等位基因数量呈正相关。在未调整的分析中,具有零个、一个和两个G1/G2风险等位基因的参与者的平均(标准误)小HDL浓度(μmol/L)分别为19.0(0.2)、19.7(0.2)和19.9(0.4)(P = 0.02)。对年龄、性别、糖尿病和非洲血统进行调整后,结果未改变,但增强了统计学显著性(P = 0.004)。根据APOL1基因型,未观察到大型或中型HDL、极低密度脂蛋白或低密度脂蛋白颗粒浓度的显著差异。
在非裔美国人中,APOL1 G1/G2风险等位基因数量越多,小HDL颗粒浓度越高。这些结果可能提示新的研究领域,以揭示APOL1风险变体与非裔美国人不良结局之间关联的原因。